Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02563002 |
|---|---|
| Brief Title: | Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177) |
| First Submitted : | September 28, 2015 |
| First Submitted that Met QC Criteria : | September 28, 2015 |
| First Posted : | September 29, 2015 (Estimate) |
| Results First Submitted : | January 6, 2022 |
| Results First Submitted that Met QC Criteria : | February 23, 2022 |
| Results First Posted : | March 16, 2022 |
| Last Update Submitted that Met QC Criteria : | July 21, 2023 |
| Last Update Posted : | July 25, 2023 |